Tetrous
SHERMAN OAKS, CA · Manufacturing · 6 employees
Tetrous, Inc. is a regenerative medicine company guided by a team of influential surgeons, and regenerative medicine scientists, and led by experienced Medical Device executives. We utilize next generation advanced technologies for tissue repair in sports medicine with initial focus on improving enthesis repair in rotator cuff repair.
Funding history
- Seed — $1.7M — Apr 2026
- Series A — $6.5M — Mar 2025
- Seed — $445K — Dec 2023
- Seed — $445K — Dec 2023
Recent signals
- Apr 22, 2026: Raised $1.7M in Seed
- Mar 24, 2026: Tetrous, Inc. Appoints Thurman Ballard as Vice President of Sales
- Mar 11, 2025: Raised $6.5M in Series A
- Dec 22, 2023: Raised $445K in Seed
- Dec 21, 2023: Raised $445K in Seed
See plans & pricing → Track Tetrous’s funding, hiring, and signals — with verified contacts — on Fundz.